4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · Real-Time Price · USD
9.77
+0.11 (1.14%)
At close: Apr 15, 2026, 4:00 PM EDT
9.46
-0.31 (-3.17%)
After-hours: Apr 15, 2026, 6:21 PM EDT

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17
Biotechnology
85.21M37.00K20.72M3.13M18.04M
Biotechnology Growth
230194.59%-99.82%562.29%-82.65%32.52%
Total
85.21M37.00K20.72M3.13M18.04M
Total Growth
230194.59%-99.82%562.29%-82.65%32.52%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17
United States
209.00K37.00K20.16M35.00K121.00K
United States Growth
464.86%-99.82%57488.57%-71.07%-
Japan
85.00M----
Netherlands
--567.00K3.09M736.00K
Netherlands Growth
---81.67%320.38%-0.81%
Switzerland
----17.18M
Switzerland Growth
----33.22%
Total
85.21M37.00K20.72M3.13M18.04M
Total Growth
230194.59%-99.82%562.29%-82.65%32.52%
Source: S&P Global Market Intelligence.